E Fund Management Co., Ltd. Atara Biotherapeutics, Inc. Transaction History

E Fund Management Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$2.8 - $5.46 $15,987 - $31,176	5,710 Added 21.67%	32,062 $93,000
Q4 2022 Feb 14, 2023	SELL	$2.85 - $5.18 $29,414 - $53,462	-10,321 Reduced 28.14%	26,352 $86,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $31,495 - $96,475	11,051 Added 43.13%	36,673 $139,000
Q2 2022 Aug 15, 2022	BUY	$4.69 - $9.84 $29,087 - $61,027	6,202 Added 31.94%	25,622 $200,000
Q1 2022 May 12, 2022	BUY	$8.44 - $16.89 $94,663 - $189,438	11,216 Added 136.71%	19,420 $180,000

Q1 2021 May 12, 2021	BUY	$14.0 - $20.72 $114,856 - $169,986	8,204 New	8,204 $117,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.